Reproductive Health Matters
Volume 16, Issue 32 , Pages 50-58 , November 2008

Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina

  • Silvina Arrossi

      Affiliations

    • Researcher, Centro de Estudios de Estado y Sociedad (CEDES) and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
  • ,
  • Silvina Ramos

      Affiliations

    • Director, CEDES, Buenos Aires, Argentina
  • ,
  • Melisa Paolino

      Affiliations

    • Research Assistant, CEDES, Buenos Aires, Argentina
  • ,
  • Rengaswamy Sankaranarayanan

      Affiliations

    • Chief, Screening Unit, International Agency for Research on Cancer, Lyon, France

References 

  1. Arrossi S, Paolino M. Argentina. Diagnóstico de Situación del Programa Nacional de Prevención de Cáncer de Cuello de Utero, y Programas Provinciales. Informe Técnico. Oficina Panamericana de la Salud. (In press 2008).
  2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer, Cancer Base No.5, Version 2.0. Lyon: IARC Press; 2004;
  3. International Agency for Research on Cancer. Cervix cancer screening. IARC working group on the evaluation of cancer preventive strategies. Lyon: IARC Press; 2004;
  4. Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Pública de México. 2003;45:S306–S314
  5. Ministerio de Salud de la Nación. Primera Encuesta Nacional de Factores de Riesgo. Buenos Aires, Ministerio de Salud. 2006;
  6. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Medicine. 2008;5(6):
  7. Ronco G, Segnan N, Ponti A. Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes. International Journal of Epidemiology. 1991;20(2):349–353
  8. Cabeza E, Esteva M, Pujol A, et al. Social disparities in breast and cervical cancer preventive practices. European Journal of Cancer Prevention. 2007;16(4):372–379
  9. Ministerio de Salud de la Nación. Encuesta Nacional de Factores de Riesgo. At: < www.msal.gov.ar/htm/Site/enfr/index.asp>
  10. Report on the Meeting: Stop Cervical Cancer. Buenos Aires, 19–20 June 2007. CD-rom, 2008.
  11. Cervical Cancer Action. Cervical Cancer Action: A Global Coalition to Stop Cervical Cancer. At: < www.cervicalcanceraction.org/home/home.php>
  12. Kane MA, Sherris J, Coursaget P, et al. Chapter 15: HPV vaccine use in the developing world. Vaccine. 2006;24(Suppl. 3):S132–S139
  13. Puig-Tintore LM, Castellsague X, Torne A, et al. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain. Journal of Lower Genital Tract Disease. 2008;12(2):82–89
  14. Sankaranarayanan R, Rajkumar R, Arrossi S, et al. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detection and Prevention. 2003;27(6):457–465
  15. Nene B, Jayant K, Arrossi S, et al. Determinants of women's participation in cervical cancer screening trial, Maharashtra, India. Bulletin of World Health Organization. 2007;85(4):264–272
  16. Bingham A, Bishop A, Coffey P, et al. Factors affecting utilization of cervical cancer prevention services. Revista Mexicana de Salud Pública. 2003;Suppl 3:S408–S416
  17. Agurto I, Bishop A, Sanchez G, et al. Perceived barriers and benefits to cervical cancer screening in Latin America. Preventive Medicine. 2004;39(1):91–98
  18. Lazcano-Ponce EC, Najera-Aguilar P, Buiatti E, et al. The cervical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control. 1997;8(5):698–704
  19. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Preventive Medicine. 2000;31(3):261–270
  20. Lazcano-Ponce EC, Moss S, Cruz-Valdez A, et al. The positive experience of screening quality among users of a cervical cancer detection center. Archives of Medical Research. 2002;33(2):186–192
  21. Lantz PM, Weigers ME, House JS. Education and income differentials in breast and cervical cancer screening. Policy implications for rural women. Medical Care. 1997;35(3):219–236
  22. Sabates R, Feinstein L. The role of education in the uptake of preventative health care: the case of cervical screening in Britain. Social Science and Medicine. 2006;62(12):2998–3010
  23. Bradley J, Risi L, Denny L. Widening the cervical cancer screening net in a South African township: who are the underserved?. Health Care for Women International. 2004;25:227–241
  24. INDEC. Encuesta Complementaria de Pueblos Indígenas. INDEC 2008. At: < www.indec.mecon.ar>
  25. Nascimento CM, Eluf-Neto J, Rego RA. Pap test coverage in São Paulo municipality and characteristics of the women tested. Bulletin of Pan American Health Organization. 1996;30(4):302–312
  26. Herrero R, Ferreccio C, Salmeron J, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine. 2008;26(Suppl):L49–L58
  27. Calle E, Flanders WD, Thun MJ, et al. Demographic predictors of mammography and Pap smear screening in US women. American Journal of Public Health. 1993;2:53–60
  28. Miller AB, Nazeer S, Fonn S, et al. Report on Consensus Conference on cervical cancer screening and management. International Journal of Cancer. 2000;86:440–447
  29. Sociedad Argentina de Patología del Tracto Genital Inferior y Colposcopía. At: < www.colpoweb.org/index.php?option=com_content&task=view&id=13&Item_id=28>
  30. Sarian LO, Derchain SF, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. Journal of Medical Screening. 2005;12(3):142–149

PII: S0968-8080(08)32410-0

doi: 10.1016/S0968-8080(08)32410-0

Reproductive Health Matters
Volume 16, Issue 32 , Pages 50-58 , November 2008